OHSU in the news

OHSU President Danny Jacobs Says Executive Vice Presidents Won’t Get Bonuses Because Money Ran Out

Willamette Week October 09, 2023
Local media report on the President's Recognition Awards for leadership and UA employees. OHSU says in a statement, "As Dr. Jacobs said when he announced the awards, the executive vice presidents’ awards were contingent upon availability of funds after all individual contributors and other UA employees were accounted for. Following these evaluations, Dr. Jacobs has determined the EVPs are not eligible for these awards."

Experts issue safety warning ahead of annular eclipse

KGW-TV October 09, 2023
To safely view the Oct. 14 annular solar eclipse and avoid developing permanent blind spots, Kavita Bhavsar, M.D., recommends wearing specialty solar eclipse glasses, which block solar rays that can damage the retina. She says: “It’s really important to wear eye protection for the entire event."

After employee uproar, OHSU scraps a controversial plan

KGW-TV October 08, 2023
Local media report on the President's Recognition Awards for leadership and UA employees. OHSU says in a statement, "As Dr. Jacobs said when he announced the awards, the executive vice presidents’ awards were contingent upon availability of funds after all individual contributors and other UA employees were accounted for. Following these evaluations, Dr. Jacobs has determined the EVPs are not eligible for these awards."

New trials, treatments show promise in treating breast cancer

The Columbian October 07, 2023
In a story on the latest research and treatment for breast cancer, Michael Cohen, Ph.D., says his lab has developed a second-generation PARP-1 inhibitor that may prove more widely effective against different forms of invasive cancer — including tough-to-treat triple-negative breast cancer. He says: “First-generation PARP inhibitors don’t do anything against triple-negative cancer. Our compounds are quite effective against triple-negative cancer cell lines.”

Unions at OHSU Petition Top Executives to Decline “Egregious” Bonuses

Willamette Week October 06, 2023
Local media report on the President's Recognition Awards for leadership and UA employees. OHSU says in a statement, "As Dr. Jacobs said when he announced the awards, the executive vice presidents’ awards were contingent upon availability of funds after all individual contributors and other UA employees were accounted for. Following these evaluations, Dr. Jacobs has determined the EVPs are not eligible for these awards."

Human physiology internships help students learn, and earn

Around the O October 06, 2023
The lab of Kerri Winters-Stone, Ph.D., is featured in an Around the O article on physiology internships designed to share learning opportunities with University of Oregon students. Student Jamie Santos shared his experience learning which exercises help improve balance in patients with cancer, who experience a loss of balance and are more likely to fall as a result. “Knowing what helped them make the decisions that they made thus far can help me navigate the foreseeable future,” he says.

OHSU vision screening program marks 20 years

KGW-TV October 05, 2023
The OHSU Casey Eye Institute’s Elks Preschool Vision Screening Program is celebrating 20 years of free vision screenings for children age 3 to 5. Joannah Vaughan says, “A lot of parents think, ‘Oh, a 3-year-old is too young for glasses,’ but this is absolutely the best time to get a child in glasses, because this is when they’re learning to read. This is when they’re interacting with other kids.”

Thrombosis Risk With Cancer Treatment Varies With VA Patient Characteristics

U.S. Medicine October 05, 2023
Via a cohort study of 434,203 veterans with solid tumors and hematologic neoplasms within the Veterans Health Administration, OHSU researchers studied whether cancer-directed therapy changed patterns of the incidence and risk of cancer-associated thrombosis (CAT) at the VA.

Uncertainty and excitement surround one company’s cell therapy for epilepsy

Spectrum October 05, 2023
A story about Neurona's development of cell therapy for epilepsy highlights a successful procedure — the second in the nation — at OHSU. Kim Burchiel, M.D., the surgeon, says, “we’re entering a new phase” for treating neurological conditions. Now the world of “neuro-restorative” treatments is opening up.
See more stories